Cargando…
Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial
BACKGROUND: Evidence for the prognostic implications of hyperglycaemia in older adults is inconsistent. OBJECTIVE: To evaluate disability-free survival (DFS) in older individuals by glycaemic status. METHODS: This analysis used data from a randomised trial recruiting 19,114 community-based participa...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128162/ https://www.ncbi.nlm.nih.gov/pubmed/37097768 http://dx.doi.org/10.1093/ageing/afad060 |
_version_ | 1785030551692902400 |
---|---|
author | Zhou, Zhen Curtis, Andrea J Owen, Alice Wolfe, Rory Murray, Anne M Tonkin, Andrew M Ernst, Michael E Orchard, Suzanne G Zhu, Chao Carr, Prudence R Reid, Christopher M Espinoza, Sara E Shah, Raj C Woods, Robyn L Ryan, Joanne McNeil, John J Nelson, Mark R Zoungas, Sophia |
author_facet | Zhou, Zhen Curtis, Andrea J Owen, Alice Wolfe, Rory Murray, Anne M Tonkin, Andrew M Ernst, Michael E Orchard, Suzanne G Zhu, Chao Carr, Prudence R Reid, Christopher M Espinoza, Sara E Shah, Raj C Woods, Robyn L Ryan, Joanne McNeil, John J Nelson, Mark R Zoungas, Sophia |
author_sort | Zhou, Zhen |
collection | PubMed |
description | BACKGROUND: Evidence for the prognostic implications of hyperglycaemia in older adults is inconsistent. OBJECTIVE: To evaluate disability-free survival (DFS) in older individuals by glycaemic status. METHODS: This analysis used data from a randomised trial recruiting 19,114 community-based participants aged ≥70 years, who had no prior cardiovascular events, dementia and physical disability. Participants with sufficient information to ascertain their baseline diabetes status were categorised as having normoglycaemia (fasting plasma glucose [FPG] < 5.6 mmol/l, 64%), prediabetes (FPG 5.6 to <7.0 mmol/l, 26%) and diabetes (self-report or FPG ≥ 7.0 mmol/l or use of glucose-lowering agents, 11%). The primary outcome was loss of disability-free survival (DFS), a composite of all-cause mortality, persistent physical disability or dementia. Other outcomes included the three individual components of the DFS loss, as well as cognitive impairment-no dementia (CIND), major adverse cardiovascular events (MACE) and any cardiovascular event. Cox models were used for outcome analyses, with covariate adjustment using inverse-probability weighting. RESULTS: We included 18,816 participants (median follow-up: 6.9 years). Compared to normoglycaemia, participants with diabetes had greater risks of DFS loss (weighted HR: 1.39, 95% CI 1.21–1.60), all-cause mortality (1.45, 1.23–1.72), persistent physical disability (1.73, 1.35–2.22), CIND (1.22, 1.08–1.38), MACE (1.30, 1.04–1.63) and cardiovascular events (1.25, 1.02–1.54) but not dementia (1.13, 0.87–1.47). The prediabetes group did not have an excess risk for DFS loss (1.02, 0.93–1.12) or other outcomes. CONCLUSIONS: Among older people, diabetes was associated with reduced DFS, and higher risk of CIND and cardiovascular outcomes, whereas prediabetes was not. The impact of preventing or treating diabetes in this age group deserves closer attention. |
format | Online Article Text |
id | pubmed-10128162 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-101281622023-04-26 Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial Zhou, Zhen Curtis, Andrea J Owen, Alice Wolfe, Rory Murray, Anne M Tonkin, Andrew M Ernst, Michael E Orchard, Suzanne G Zhu, Chao Carr, Prudence R Reid, Christopher M Espinoza, Sara E Shah, Raj C Woods, Robyn L Ryan, Joanne McNeil, John J Nelson, Mark R Zoungas, Sophia Age Ageing Research Paper BACKGROUND: Evidence for the prognostic implications of hyperglycaemia in older adults is inconsistent. OBJECTIVE: To evaluate disability-free survival (DFS) in older individuals by glycaemic status. METHODS: This analysis used data from a randomised trial recruiting 19,114 community-based participants aged ≥70 years, who had no prior cardiovascular events, dementia and physical disability. Participants with sufficient information to ascertain their baseline diabetes status were categorised as having normoglycaemia (fasting plasma glucose [FPG] < 5.6 mmol/l, 64%), prediabetes (FPG 5.6 to <7.0 mmol/l, 26%) and diabetes (self-report or FPG ≥ 7.0 mmol/l or use of glucose-lowering agents, 11%). The primary outcome was loss of disability-free survival (DFS), a composite of all-cause mortality, persistent physical disability or dementia. Other outcomes included the three individual components of the DFS loss, as well as cognitive impairment-no dementia (CIND), major adverse cardiovascular events (MACE) and any cardiovascular event. Cox models were used for outcome analyses, with covariate adjustment using inverse-probability weighting. RESULTS: We included 18,816 participants (median follow-up: 6.9 years). Compared to normoglycaemia, participants with diabetes had greater risks of DFS loss (weighted HR: 1.39, 95% CI 1.21–1.60), all-cause mortality (1.45, 1.23–1.72), persistent physical disability (1.73, 1.35–2.22), CIND (1.22, 1.08–1.38), MACE (1.30, 1.04–1.63) and cardiovascular events (1.25, 1.02–1.54) but not dementia (1.13, 0.87–1.47). The prediabetes group did not have an excess risk for DFS loss (1.02, 0.93–1.12) or other outcomes. CONCLUSIONS: Among older people, diabetes was associated with reduced DFS, and higher risk of CIND and cardiovascular outcomes, whereas prediabetes was not. The impact of preventing or treating diabetes in this age group deserves closer attention. Oxford University Press 2023-04-23 /pmc/articles/PMC10128162/ /pubmed/37097768 http://dx.doi.org/10.1093/ageing/afad060 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Research Paper Zhou, Zhen Curtis, Andrea J Owen, Alice Wolfe, Rory Murray, Anne M Tonkin, Andrew M Ernst, Michael E Orchard, Suzanne G Zhu, Chao Carr, Prudence R Reid, Christopher M Espinoza, Sara E Shah, Raj C Woods, Robyn L Ryan, Joanne McNeil, John J Nelson, Mark R Zoungas, Sophia Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial |
title | Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial |
title_full | Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial |
title_fullStr | Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial |
title_full_unstemmed | Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial |
title_short | Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial |
title_sort | prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the aspirin in reducing events in the elderly trial |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128162/ https://www.ncbi.nlm.nih.gov/pubmed/37097768 http://dx.doi.org/10.1093/ageing/afad060 |
work_keys_str_mv | AT zhouzhen prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial AT curtisandreaj prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial AT owenalice prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial AT wolferory prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial AT murrayannem prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial AT tonkinandrewm prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial AT ernstmichaele prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial AT orchardsuzanneg prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial AT zhuchao prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial AT carrprudencer prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial AT reidchristopherm prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial AT espinozasarae prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial AT shahrajc prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial AT woodsrobynl prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial AT ryanjoanne prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial AT mcneiljohnj prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial AT nelsonmarkr prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial AT zoungassophia prediabetesdiabetesandlossofdisabilityfreesurvivalinacommunitybasedoldercohortaposthocanalysisoftheaspirininreducingeventsintheelderlytrial |